sdb-001 and Multiple-Sclerosis

sdb-001 has been researched along with Multiple-Sclerosis* in 1 studies

Other Studies

1 other study(ies) available for sdb-001 and Multiple-Sclerosis

ArticleYear
Amidoalkylindoles as Potent and Selective Cannabinoid Type 2 Receptor Agonists with in Vivo Efficacy in a Mouse Model of Multiple Sclerosis.
    Journal of medicinal chemistry, 2017, 08-24, Volume: 60, Issue:16

    Selective CB

    Topics: Adamantane; Animals; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; CHO Cells; Cricetulus; Female; Indoles; Ligands; Mice, Inbred C57BL; Molecular Docking Simulation; Multiple Sclerosis; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship

2017